Kirkland Advises Thoma Bravo on $60 Million Investment in IAC’s Vivian Health

Kirkland & Ellis advised Thoma Bravo on its lead role in a $60 million primary and secondary equity investment in Vivian Health, an IAC (NASDAQ: IAC) company and a leading healthcare jobs marketplace serving healthcare professionals first, with participation from IAC and Collaborative Fund. The new capital will be used to accelerate Vivian's rapid growth and further its scale among healthcare clinicians and employers, as well as to support future M&A initiatives.

Read the Thoma Bravo press release

The Kirkland team was led by corporate partner Leon Johnson and associates Ryan Slaugh and Dane Christensen, with support from corporate partner Jon-Micheal Wheat, and also included tax partners Adam Kool and Kevin Coenen and associate Steven Cantor, technology & IP transactions partners Seth Traxler and Aaron Lorber and associate Jessie Perlman, labor & employment partner Michael Schulman and associate Alexis Grinstead, employee benefits partner Matt Antinossi and associate Nate Linger, executive compensation partner Jared Whalen and associate James Sprague and ESG & impact partner Sara Orr and associate Kyle Guest.